Project Grant K43TW012641

Award Date 7/15/23
Completion Date 4/30/28
Dollars Obligated $5
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Kenya
Similar Awards
This Project Grant award of $162,820 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports research to develop a community-clinical linkage model to facilitate referral of people living with HIV (PLWH) and comorbid hypertension to primary healthcare centers in Akwa Ibom, Nigeria. The research aims are to: 1) identify barriers and facilitators to this model, 2) co-develop a culturally-tailored,...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) aims to integrate a pharmacy technician-based model for delivering long-acting injectable cabotegravir-rilpivirine (LA-CAB/RPV) into community-based Federally Qualified Health Centers (FQHCs) that serve underserved people with HIV. The $1.2M award to the University of Chicago will fund a 5-year study to adapt and test this model in 5 FQHC clinics in Chicago,...
This $196,881 Project Grant was awarded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) to adapt and pilot test an intervention to reduce alcohol use and improve HIV care outcomes among men living with HIV who have serodiscordant pregnant partners in Uganda. The overarching goal is to adapt the KISOBOKA intervention, which utilizes motivational interviewing and behavioral economics techniques, for use with this target...
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to externally validate and refine an agent-based model that simulates the effects of implementation strategies on improving hypertension care guidelines for persons with HIV in Indiana. The total funding amount for this 2-year project is $118,875, with an award date of September 1, 2024. The key objectives are to: 1) externally...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a comprehensive study to determine the prevalence and clinical characteristics of mild cognitive impairment (MCI) and Alzheimer's-related dementia (ADRD) among older adults living with HIV in Uganda. The $1,103,953 award, which began on Sep 15, 2024 and runs through Aug 31, 2025, will fund the following key activities: Comprehensive neuropsychological assessments among 600 older...
This Project Grant award of $469,291, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program, supports a hybrid implementation-effectiveness trial to evaluate an algorithm-driven implementation strategy for a comprehensive care management and care coordination (CCM/CC) intervention for people with HIV (PWH). The project aims to: 1) Examine the effectiveness of the algorithm-driven CCM/CC implementation strategy on improving HIV...
The University of North Carolina at Chapel Hill (UNC-CH) received a $1 Project Grant award from the National Institutes of Health Fogarty International Center (CFDA 93.989 - International Research and Research Training) on September 1, 2024 to conduct the "KUPAMBANA: A Combined Microeconomic Strengthening and Stigma Reduction Intervention for Young People with HIV in Zambia" project. The project aims to address the intersectional challenges of HIV and poverty stigma among young...

COMMUNITY-BASED MEDICATION ADHERENCE SUPPORT FOR OLDER ADULTS LIVING WITH HIV AND HYPERTENSION (CBA INTERVENTION) - PROJECT SUMMARY DUE TO THE INCREASING AVAILABILITY OF ART, PEOPLE LIVING WITH HIV (PLWH) ARE SURVIVING LONGER AND ACHIEVING LIFE EXPECTANCIES SIMILAR TO THE GENERAL POPULATION. WHILE THIS IS A GREAT ACHIEVEMENT, NONCOMMUNICABLE DISEASES SUCH AS CARDIOVASCULAR DISEASE (CVD) NOW ACCOUNT FOR A SIGNIFICANT PROPORTION OF THE MORBIDITY AND MORTALITY IN PLWH. POOR HTN MEDICATION ADHERENCE IS ASSOCIATED WITH UNCONTROLLED BLOOD PRESSURE (BP) AND INCREASED RISK OF CVD EVENTS SUCH AS MYOCARDIAL INFARCTION. DESPITE THIS RISK, MEDICATION ADHERENCE RESEARCH IN PLWH IS PRIMARILY FOCUSED ON ART WITH LIMITED FOCUS ON ADHERENCE TO OTHER CHRONIC COMORBIDITIES. MEDICATION ADHERENCE IS A COMPLEX HEALTH BEHAVIOUR THAT IS DRIVEN BY CONFLUENCE OF FACTORS THAT OPERATE AT MICRO- AND MACRO-LEVELS. AS PEOPLE AGE WITH HIV, THEIR NEEDS INCREASE BEYOND SOLELY MANAGING HIV MEDICATION ADHERENCE, TO INCLUDE MANAGEMENT OF OTHER CONDITIONS AND THEIR MEDICATIONS. INCREASED PILL BURDEN FACED BY OLDER ADULTS LIVING WITH HIV (OALWH) WITH HTN, COUPLED WITH DECLINE IN COGNITIVE FUNCTION, COST OF TRANSPORTATION TO THE FACILITY TO GET MEDICATION REFILL AND LACK OF SOCIAL SUPPORT WORSEN ADHERENCE. DIFFERENCES IN ACCESS PARTICULARLY IN LMICS, WHERE ART IS FREE AND HTN MEDICATION ARE NOT, WIDER ADVERSE EFFECT PROFILES OF HTN DRUGS, AND LACK OF POLYPILLS IN HTN CARE COULD ALSO CONTRIBUTE TO NON-ADHERENCE. ADHERENCE SUPPORT FOR OALWH WITH HTN TARGETED AT THESE FACTORS MAY HELP IMPROVE MEDICATION ADHERENCE AND REDUCE CVD EVENTS. IN THIS K43 APPLICATION, THE APPLICANT PROPOSES A TRAINING PLAN THAT WILL ENABLE HER GAIN SKILLS AND EXPERTISE IN HUMAN-CENTERED DESIGN APPROACH, IMPLEMENTATION SCIENCE THEORIES, MODELS AND FRAMEWORKS, AND ECONOMIC EVALUATION OF HEALTH INTERVENTIONS. HER RESEARCH WILL ADDRESSING THE FOLLOWING SPECIFIC AIMS: CO-DESIGN A NOVEL CHV-LED MODEL FOR MEDICATION ADHERENCE SUPPORT (CBA INTERVENTION) FOR OALWH USING A HUMAN-CENTERED DESIGN APPROACH (AIM 1); CONDUCT A PILOT OF CBA INTERVENTION AND EVALUATE ITS FEASIBILITY (AIM2); AND CONDUCT COSTING AND BUDGET IMPACT ANALYSIS OF CBA INTERVENTION (AIM 3). THE PROPOSED K43 CAREER DEVELOPMENT ACTIVITIES INCLUDING THE OUTCOME OF THE PROPOSED RESEARCH WILL CULMINATE IN MY TRANSITION TO AN INDEPENDENT RESEARCHER (R01-FUNDED), CONTRIBUTING IN THE FIELD OF HIV AND AGING.

Posted 7/17/23, 12:00 AM